{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:21:35Z","timestamp":1771654895275,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010956","name":"State University of New York Upstate Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022905","name":"Upstate Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005301","name":"American College of Surgeons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clml.2023.08.015","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T11:39:10Z","timestamp":1692617950000},"page":"897-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Descriptive Analysis and Factors Influencing Survival in Patients With Primary Cutaneous Gamma-Delta T Cell Lymphoma. A Retrospective National Cancer Database Study."],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6236-2822","authenticated-orcid":false,"given":"Prashanth","family":"Ashok Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abirami","family":"Sivapiragasam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clml.2023.08.015_bib0001","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1042\/BST20200890","article-title":"Our evolving understanding of the role of the \u03b3\u03b4 T cell receptor in \u03b3\u03b4 T cell mediated immunity","volume":"49","author":"Gully","year":"2021","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"10.1016\/j.clml.2023.08.015_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-024-06014-9","article-title":"Gamma-delta (\u03b3\u03b4) T cells: friend or foe in cancer development?","volume":"16","author":"Zhao","year":"2018","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.clml.2023.08.015_bib0003","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/ejh.12439","article-title":"Gamma-delta t-cell lymphomas","volume":"94","author":"Foppoli","year":"2015","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.clml.2023.08.015_bib0004","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/PAS.0b013e318275d1a2","article-title":"TCR-\u03b3 expression in primary cutaneous T-cell lymphomas","volume":"37","author":"Rodr\u00edguez-Pinilla","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.clml.2023.08.015_bib0005","first-page":"e10386","article-title":"Primary cutaneous gamma\/delta T-cell lymphoma and hemophagocytic lymphohistiocytosis associated with AIDS","volume":"12","author":"Khadilkar","year":"2020","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.clml.2023.08.015_bib0006","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/dermatopathology8040054","article-title":"Primary cutaneous gamma-delta T cell lymphomas: a case series and overview of the literature","volume":"8","author":"Alberti-Violetti","year":"2021","journal-title":"Dermatopathology"},{"key":"10.1016\/j.clml.2023.08.015_bib0007","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fonc.2020.00133","article-title":"Primary cutaneous gamma-delta T-cell lymphoma with long-term indolent clinical course initially mimicking lupus erythematosus profundus","volume":"10","author":"von D\u00fccker","year":"2020","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.clml.2023.08.015_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-021-03525-6","article-title":"Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a national cancer database study","volume":"147","author":"Ashok Kumar","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"10.1016\/j.clml.2023.08.015_bib0009","first-page":"e27109","article-title":"Current trends in the management of epithelial lacrimal gland tumors: a retrospective national cancer database analysis","volume":"14","author":"Kumar","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.clml.2023.08.015_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s44228-022-00011-9","article-title":"Clinical, diagnostic and prognostic characteristics of primary cutaneous gamma delta T-cell lymphomas","volume":"4","author":"Muhsen","year":"2022","journal-title":"Clin Hematol Int"},{"issue":"16","key":"10.1016\/j.clml.2023.08.015_bib0011","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2023.08.015_bib0012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0625.1992.tb00069.x","article-title":"T-cell receptor gamma delta-positive peripheral T-cell lymphomas presenting in the skin: a clinical, histological and immunophenotypic study","volume":"1","author":"Ralfkiaer","year":"1992","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.clml.2023.08.015_bib0013","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/jdds.jdds_54_21","article-title":"Primary cutaneous gamma-delta T-cell lymphoma: two cases and a review of the literature","volume":"25","author":"Hrin","year":"2021","journal-title":"J Dermatol Dermatol Surg"},{"issue":"Supplement_1","key":"10.1016\/j.clml.2023.08.015_bib0014","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/blood-2019-130223","article-title":"Characteristics, treatment patterns, and outcomes in primary cutaneous gamma delta T cell lymphoma (PCGDTCL): a real world multi-institutional analysis of a rare malignancy","volume":"134","author":"David","year":"2019","journal-title":"Blood"},{"issue":"0","key":"10.1016\/j.clml.2023.08.015_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21037\/aol-21-41","article-title":"The gamma delta lymphomas: an Australian multi-centre case series","volume":"6","author":"Harrop","year":"2022","journal-title":"Ann Lymphoma"},{"key":"10.1016\/j.clml.2023.08.015_bib0016","first-page":"2510","article-title":"Report of eleven patients of subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic features, 18F-FDG PET\/CT findings and outcome","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.clml.2023.08.015_bib0017","first-page":"1","article-title":"Recent advances in cutaneous lymphoma\u2014implications for current and future classifications","volume":"1","author":"Goodlad","year":"2022","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.clml.2023.08.015_bib0018","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41467-020-15572-7","article-title":"Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas","volume":"11","author":"Daniels","year":"2020","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.clml.2023.08.015_bib0019","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous \u03b3\u03b4 T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.clml.2023.08.015_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.25674","article-title":"Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas","volume":"95","author":"Foss","year":"2020","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.clml.2023.08.015_bib0021","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/ajh.26299","article-title":"Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management","volume":"96","author":"Hristov","year":"2021","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.clml.2023.08.015_bib0022","doi-asserted-by":"crossref","first-page":"e0199745","DOI":"10.1371\/journal.pone.0199745","article-title":"Disparities by race, age, and sex in the improvement of survival for lymphoma: findings from a population-based study","volume":"13","author":"Mukhtar","year":"2018","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.clml.2023.08.015_bib0023","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1200\/JCO.19.00812","article-title":"Survival by race and ethnicity in pediatric and adolescent patients with Hodgkin lymphoma: a children's oncology group study","volume":"37","author":"Kahn","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clml.2023.08.015_bib0024","first-page":"60","article-title":"Racial and ethnic disparities among participants in US-based phase 3 randomized cancer clinical trials","volume":"4","author":"Grant","year":"2020","journal-title":"JNCI Cancer Spectr"},{"issue":"6","key":"10.1016\/j.clml.2023.08.015_bib0025","first-page":"e25867","article-title":"Racial disparities in survival among non-hodgkin lymphoma patients: an analysis of the SEER database (2007-2015)","volume":"14","author":"Abodunrin","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.clml.2023.08.015_bib0026","unstructured":"Participant User Files | ACS. Accessed March 8, 2023. Available from: https:\/\/www.facs.org\/quality-programs\/cancer-programs\/national-cancer-database\/puf\/."}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023002756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023002756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:43:54Z","timestamp":1761871434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265023002756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2152265023002756"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2023.08.015","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Descriptive Analysis and Factors Influencing Survival in Patients With Primary Cutaneous Gamma-Delta T Cell Lymphoma. A Retrospective National Cancer Database Study.","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2023.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}